(tisagenlecleucel) Autologous T Cells transduced with lentiviral vector containing a chimeric antigen receptor directed against CD19

(tisagenlecleucel) Autologous T Cells transduced with lentiviral vector containing a chimeric antigen receptor directed against CD19
Trade Name Kymriah (Tisagenlecleucel)
Orphan Indication Acute lymphoblastic leukemia
USA Market Approval USA
USA Designation Date 2014-01-31 00:00:00
Sponsor Novartis Pharmaceuticals Corporation;One Health Plaza;East Hanover, New Jersey, 07936
Related Access Program
Novartis Pharmaceuticals – Acute Lymphoblastic Leukemia University of California, San Francisco – Acute Lymphoblastic Leukemia ERYtech Pharma – Acute Lymphoblastic Leukemia University of California, San Francisco – Acute lymphoblastic leukemia ERYtech Pharma – Acute lymphoblastic leukemia Amgen – Acute lymphoblastic leukemia